Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alnylam pharmaceuticals
boston
3
×
boston blog main
boston top stories
fda
life sciences
national blog main
onpattro
patisiran
3
×
akcea therapeutics
clinical trials
drugs
hereditary transthyretin amyloidosis
inotersen
national top stories
new york blog main
new york top stories
pfizer
rna interference
san diego blog main
san diego top stories
tafamidis
acute hepatic porphyrias
akin akinc
aminolevulinic acid
andrew fire
craig mello
european medicines agency
givosiran
harvard pilgrim health care
institute for clinical and economic review
john maraganore
nobel prize
paul matteis
san francisco blog main
san francisco top stories
stifel financial
vyndaqel
What
alnylam
drug
fda
medicine
rnai
3
×
interference
pharmaceuticals
rna
afternoon
ago
alnylam’s
approval
approved
approves
cells
ema
employ
europe
follows
gene
gets
harmful
history
hits
indicated
landmark
make
making
method
mute
nod
ok
onpattro
patisiran
protein
quick
second
seek
specifically
speedy
Language
Current search:
patisiran
×
rnai
×
boston
×
@xconomy.com
5 years ago
Alnylam Won’t Seek Quick FDA Nod For Second RNAi Drug
@xconomy.com
5 years ago
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug
@xconomy.com
5 years ago
Alnylam Gets Landmark FDA OK For First-Ever RNAi Drug